Nano particle loaded EZH2 inhibitors: Increased efficiency and reduced toxicity for malignant solid tumors
{{output}}
Background and objectives: Aberrant upregulation or mutations of EZH2 frequently occur in human cancers. However, the clinical benefits of EZH2 inhibitors (EZH2i) remain unsatisfactory for majority of solid tumors. Therefore, the... ...
